Zy Spy an IPO: Of Zymergen and its monster public company debut, and the risks investors love
In California, Zymergen raised $500 million last week in its IPO and the stock closed Monday night at $43.00, up 39 percent over itsWednesday trading debut. The company sold an unexpectedly robust $16.1 million shares at $31, the top end of its expected range. In short, every sign from the market is bullish. For many […]














